Shawn Harriman

Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy.

Jean S. Beebe, Jitesh P. Jani, Elisabeth Knauth et al. · PubMed · 2003 · 128 citations

Medicine, Oncology, Pharmacology +16

The development of a higher throughput reactive intermediate screening assay incorporating micro-bore liquid chromatography–micro-electrospray ionization–tandem mass spectrometry and glutathione ethyl ester as an in vitro conjugating agent

John R. Soglia, Shawn Harriman, Sabrina X. Zhao et al. · Journal of Pharmaceutical and Biomedical Analysis · 2004 · 109 citations

Pharmacy, Toxicology, Analytical Chemistry +13

Comprehensive Assessment of Human Pharmacokinetic Prediction Based on In Vivo Animal Pharmacokinetic Data, Part 2: Clearance

Franco Lombardo, Nigel J. Waters, Upendra A. Argikar et al. · The Journal of Clinical Pharmacology · 2012 · 99 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Metabolic stereoisomeric inversion of ibuprofen in mammals

Ching‐Shih Chen, Woan-Ru Shieh, Pei-Heng Lu et al. · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · 1991 · 97 citations

Medicine, Medicinal Chemistry, Pharmacology +7

Formation of Cyclopropanone during Cytochrome P450-Catalyzed N-Dealkylation of a Cyclopropylamine

Christopher L. Shaffer, Shawn Harriman, Yakov M. Koen et al. · Journal of the American Chemical Society · 2002 · 87 citations

Medicine, Biochemistry, Pharmacology +17